share_log

BRIEF-Virpax Pharmaceuticals Inc To Develop Intranasal Cannabidiol Product To Manage Epilepsy In Adults And Children

reuters ·  Sep 20, 2021 09:30

Sept 20 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :

* VIRPAX TO DEVELOP INTRANASAL CANNABIDIOL PRODUCT FOR THE MANAGEMENT OF EPILEPSY IN ADULTS AND CHILDREN

* VIRPAX - ACQUIRED EXCLUSIVE WORLDWIDE RIGHTS FROM NANOMERICS TO USE NANOMERIC'S MET FOR NASAL DELIVERY OF CBD FOR MANAGEMENT OF EPILEPSY IN ADULTS, CHILDREN

Source text for Eikon: ID:nBwbHlsyfa Further company coverage: VRPX.O

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment